Tumor Imaging Metrics
Tumor Imaging Metrics Core
The mission of the Tumor Imaging Metrics Core (TIMC) is to provide standardized, consistent, longitudinal radiological measurements to evaluate therapeutic response for DF/HCC clinical trials.
The TIMC -
- Makes reliable, quantitative, longitudinal measurements (such as RECIST, WHO, SWOG, standardized uptake value [SUV] etc.) of lesions from serial MRI, CT, PET, and PET/CT scan images
- Presents results of analyses on a password protected secure web-based report
- Provides an independent service, with verifiable measurement of treatment response for patients enrolled in cancer center trials
- Serves as a centralized, computerized resource to facilitate efficient internal or external auditing
Reliable tracking of changes in lesion size or metabolism is essential for clinical trials that use radiological measurements as surrogate endpoints. The Tumor Metrics Core provides a service for managing these images, making measurements in a routine, reliable, and centralized way, and making results available to investigators efficiently.
PUBLICATION ACKNOWLEDGEMENT: If research supported by this core facility results in publication, please acknowledge this support by including the following in your publication(s):
We thank Dana-Farber/Harvard Cancer Center in Boston, MA, for the use of the Tumor Imaging Metrics Core, which provided __________ service. Dana-Farber/Harvard Cancer Center is supported in part by an NCI Cancer Center Support Grant # NIH 5 P30 CA06516.